Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Weissman

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Chest|January 16, 2015
Myocardial Dysfunction in Severe Sepsis and Septic Shock: No Correlation With Inflammatory Cytokines in Real-life Clinical SettingGiora Landesberg, Phillip D Levin, Dan Gilon, et al.
European Heart Journal|November 30, 2006
A clinical survival score predicts the likelihood to benefit from preoperative thallium scanning and coronary revascularization before major vascular surgeryGiora Landesberg, Yacov Berlatzky, Moshe Bocher, et al.
Critical Care (London, England)|November 10, 2005
Clinical review: the Israeli experience: conventional terrorism and critical careGabriella Aschkenasy-Steuer, Micha Shamir, Avraham Rivkind, et al.
Critical Care Medicine|December 25, 2013
Troponin elevation in severe sepsis and septic shock: the role of left ventricular diastolic dysfunction and right ventricular dilatation*Giora Landesberg, Allan S Jaffe, Dan Gilon, et al.
Shock (Augusta, Ga.)|July 6, 2019
Early Maladaptive Cardiovascular Responses are Associated with Mortality in a Porcine Model of Hemorrhagic ShockRuth Shaylor, Lilach Gavish, Gal Yaniv, et al.
European Heart Journal|September 14, 2011
Diastolic dysfunction and mortality in severe sepsis and septic shockGiora Landesberg, Dan Gilon, Yuval Meroz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2006
Randomized phase II trial of pemetrexed combined with either cisplatin or carboplatin in untreated extensive-stage small-cell lung cancerMark A Socinski, Charles Weissman, Lowell L Hart, et al.
Oral Oncology|January 17, 2015
A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancerAntonio Jimeno, Julie E Bauman, Charles Weissman, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Chest|January 16, 2015
Myocardial Dysfunction in Severe Sepsis and Septic Shock: No Correlation With Inflammatory Cytokines in Real-life Clinical SettingGiora Landesberg, Phillip D Levin, Dan Gilon, et al.
European Heart Journal|November 30, 2006
A clinical survival score predicts the likelihood to benefit from preoperative thallium scanning and coronary revascularization before major vascular surgeryGiora Landesberg, Yacov Berlatzky, Moshe Bocher, et al.
Critical Care (London, England)|November 10, 2005
Clinical review: the Israeli experience: conventional terrorism and critical careGabriella Aschkenasy-Steuer, Micha Shamir, Avraham Rivkind, et al.
Critical Care Medicine|December 25, 2013
Troponin elevation in severe sepsis and septic shock: the role of left ventricular diastolic dysfunction and right ventricular dilatation*Giora Landesberg, Allan S Jaffe, Dan Gilon, et al.
Shock (Augusta, Ga.)|July 6, 2019
Early Maladaptive Cardiovascular Responses are Associated with Mortality in a Porcine Model of Hemorrhagic ShockRuth Shaylor, Lilach Gavish, Gal Yaniv, et al.
European Heart Journal|September 14, 2011
Diastolic dysfunction and mortality in severe sepsis and septic shockGiora Landesberg, Dan Gilon, Yuval Meroz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2006
Randomized phase II trial of pemetrexed combined with either cisplatin or carboplatin in untreated extensive-stage small-cell lung cancerMark A Socinski, Charles Weissman, Lowell L Hart, et al.
Oral Oncology|January 17, 2015
A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancerAntonio Jimeno, Julie E Bauman, Charles Weissman, et al.
Pageof 10